Title page; Preface; List of Contributors; Contents; Conference Preface; Keynote Lecture -- Risk Factors for Atherosclerotic Disease: Present and Future; Microdetermination of Fatty Acids by Gas Chromatography and Cardiovascular Risk Stratification by the "EPA+DHA Level"; Highly Purified Omega-3 Polyunsaturated Fatty Acids Are Effective as Adjunct Therapy for Secondary Prevention of Myocardial Infarction: Critical Analysis of GISSI-Prevenzione Trial; Prevention of Cardiovascular Diseases and Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs)
Omega-3 Fatty Acids and Sudden Arrhythmic DeathDepression and Coronary Artery Disease: Epidemiology and Potential Mechanisms; Effects of Omega-3 Polyunsaturated Fatty Acids on Depression; A Multi-Country Health-Economic Evaluation of Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs) in the Secondary Prevention After Myocardial Infarction (MI); OMACOR® in Clinical Development: A Survey of Current Trials; Author Index
Summary
Solvay Pharmaceuticals Conferences
Notes
Held during the European Cardiology Society Congress in Stockholm in 2005
